The Cancer Letter

Inside information on cancer research and drug development

Vol.
20
No.
13
April 01, 1994Apr 01, 1994
Free
DOWNLOAD THE PDF

Second Irregularity In NSABP Data Found; Fisher Takes Leave As Group’s Chairman

In Brief: Ross Retires From Bristol-Myers, Forms Own Consulting Service; Obey Wins Key Post

NCI Promises Strong Monitoring Process Visco Calls For Independent Review; Rep. Dingell Plans Hearing April 13

Biotech Organization Endorses Measures On Orphan Drug Act

Salick Signs contract for Fixed-Price Oncology Services

DCE Advisors OK RFAs In Occupational Cancer, H. Pylori

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.
COMPLETE OUR SURVEY

Login

Site license subscribers:
Log in with your IP | Register a sponsored account